Epoetin Alfa
Links shared publicly online about this topic
FDA Alert: Epogen and Procrit (epoetin alfa): Recall - Particulate Matter in Vials
drugs.com — “FDA Alert: Epogen and Procrit (epoetin alfa): Recall - Particulate Matter in Vials” View full resource at drugs.com
Most Recently Shared on September 27, 2010 at 10:07 pm By:
FDA Alert - Recall: Epogen and Procrit (epoetin alfa) - Particulate Matter in Vials - http://bit.ly/d6cAQn
Epoetin alfa had no effect on survival, tumor outcomes in head and neck cancers | HemOncToday
hemonctoday.com — “Adding epoetin alfa to radiotherapy had no effect on survival, tumor outcomes, anemia or fatigue for patients with head and neck cancers. </P” View full resource at hemonctoday.com
Most Recently Shared on November 19, 2009 at 2:05 pm By:
HemOnc Today Oncology and Health News
Epoetin alfa had no effect on survival, tumor outcomes in head and neck cancers http://ow.ly/DGjt
HCV New Drug Research: Modifications; Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Modifications; Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on June 24, 2011 at 5:40 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Modifications; Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease http://goo.gl/fb/yj6Lm
Janssen Products, LP Modifies Prescribing Information for PROCRIT (Epoetin alfa) in Chronic Kidney Disease - Drugs.com MedNews
drugs.com — “Revised prescribing information reflects FDA guidance to update labeling for all drugs within ESA class HORSHAM, Pa., Janssen Products, LP, formerly Centocor Or” View full resource at drugs.com
Most Recently Shared on June 24, 2011 at 9:06 pm By:
Drugs and Devices OW OW Health
Janssen Products, LP Modifies Prescribing Information for PROCRIT (Epoetin alfa) in Chronic Kidney Disease... http://bit.ly/m5idvC #drug
NCI Cancer Bulletin for August 5, 2008 - National Cancer Institute
cancer.gov — “NCI's biweekly online newsletter provides useful, timely information about cancer research to the cancer community.” View full resource at cancer.gov
Most Recently Shared on February 16, 2010 at 5:45 pm By:
NCI Cancer Bulletin Health News
FDA requiring risk mgmt program for anti-anemia drugs in cancer patients: http://bit.ly/b5q1E4 More on ESAs: http://bit.ly/boaLCS
Centocor Ortho Biotech Products And Amgen Finalize ESA Risk Evaluation And Mitigation Strategy (REMS) With FDA
medicalnewstoday.com — “Centocor Ortho Biotech Products, L.P. and Amgen Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-s” View full resource at medicalnewstoday.com
Most Recently Shared on February 17, 2010 at 8:13 pm By:
Centocor Ortho Biotech Products And Amgen Finalize ESA Risk Evaluation And Mitigation Strategy (REMS) With FDA http://mnt.to/3xJ9 #cancer
Health Tip: Is Your Red Face Really Rosacea? - Drugs.com MedNews
drugs.com — “Rosacea is a recurring skin condition characterized by red, ruddy skin, especially on the face. The U.S. National Library of Medicine mentions these additional” View full resource at drugs.com
Most Recently Shared on September 30, 2010 at 3:08 pm By:
Drugs and Devices OW OW Health
Health Tip: Is Your Red Face Really Rosacea?: -- Rosacea is a recurring skin condition characterized by red, ... http://bit.ly/cRgCRP #drug
Health Tip: Ward Off Tooth Decay - Drugs.com MedNews
drugs.com — “Tooth decay usually occurs when bacteria eat away at enamel that covers the teeth, frequently causing cavities. The American Dental Association suggests these s” View full resource at drugs.com
Most Recently Shared on September 28, 2010 at 2:14 pm By:
Drugs and Devices OW OW Health
Health Tip: Ward Off Tooth Decay: -- Tooth decay usually occurs when bacteria eat away at enamel that covers ... http://bit.ly/cLFdnt #drug
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials : The Lancet
thelancet.com — “Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. By - Julia Bohlius MD, Kurt Schmidlin DMD, Corinne Brillant MSc, Gui...” View full resource at thelancet.com
Most Recently Shared on May 1, 2009 at 8:56 am By:
[The Lancet] [Articles] Recombinant human erythropoiesis-stimulating agents and mortality in patient.. http://tinyurl.com/cklf2y
FDA Announces New Safety Plan for Agents Used to Treat Chemotherapy-Related Anemia
fda.gov — “The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program is also designed to help ensure the appropriate administration of these drugs, which they receive to treat anemia that can occur as a result of chemotherapy.” View full resource at fda.gov
Most Recently Shared on February 16, 2010 at 5:24 pm By:
FDA Announces New Safety Plan for Agents Used to Treat Chemotherapy-Related Anemiahttp://bit.ly/bUjmMr
Lots of Epogen and Procrit Recalled Due to Glass Flakes in Vials - QualityPoint Technologies
qualitypointtech.net — “Several lots epoetin alfa vials are subject to recall, according to an FDA alert. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on September 27, 2010 at 7:00 pm By:
Lots of Epogen and Procrit Recalled Due to Glass Flakes in Vials: Several lots epoetin alfa vials are subject to r... http://bit.ly/a5QdHN
Oncology Medical News about Anemia
mdlinx.com — “A Randomized Controlled Study Comparing Once-Weekly to Every-2-Week and Every-4-Week Dosing of Epoetin Alfa in CKD Patients with Anemia” View full resource at mdlinx.com
Most Recently Shared on April 23, 2010 at 8:17 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A Randomized Controlled Study Comparing Once-Weekly to Every-2-Week and Every-4-Week Dosing of Epoetin Al... http://bit.ly/bRchWS #oncology
Amgen recalls certain lots of Epogen and Procrit - MPR
empr.com — “Amgen and Centocor Ortho Biotech announced a voluntary nationwide recall of certain lots of Epogen (epoetin alfa) and Procrit (epoetin alfa) vials that may contain extremely thin glass flakes (lamellae) that are barely visible in most cases.” View full resource at empr.com
Most Recently Shared on September 24, 2010 at 5:04 pm By:
MPR News: Amgen recalls certain lots of Epogen and Procrit: Amgen and Centocor Ortho Biotech announced a voluntary... http://bit.ly/96iZqf
Oncology Medical News about Dialysis
mdlinx.com — “Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial” View full resource at mdlinx.com
Most Recently Shared on June 18, 2010 at 9:17 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin... http://bit.ly/a2SAVz #oncology
ASN: ESA Protocol Reduces Exposure, Preserves Hemoglobin (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “DENVER (MedPage Today) -- Dialysis patients had less exposure to epoetin alfa with no deterioration of hemoglobin values when they were switched from an intravenous to a subcutaneous protocol, according to a study reported here.” View full resource at qualitypointtech.net
Most Recently Shared on November 22, 2010 at 4:03 am By:
ASN: ESA Protocol Reduces Exposure, Preserves Hemoglobin (CME/CE): DENVER (MedPage Today) -- Dialysis patients had... http://bit.ly/dxvN8O
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
HemOnc Today
The official Twitter feed for HemOnc Today, offering news and perspectives in hematology and oncology.
-
Tina Banwart - HepatitisCNewDrugs
Advertisement
